A
VNDA icon

AJOVista’s Vanda Pharmaceuticals VNDA Stock Holding History

AJOVista’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$54.2K Buy
+11,552
New +$61.9K 0.23% 97

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJOVista's VNDA Position: Q3 2024 in Review

AJOVista opened a new position in Vanda Pharmaceuticals (VNDA) in Q3 2024: 11,552 shares worth $54.2K. The stake represents 0.23% of the portfolio and ranks #97 among its holdings.

152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • AJOVista held 11,552 shares of Vanda Pharmaceuticals worth $54.2K as of Q3 2024.
  • Vanda Pharmaceuticals was a new AJOVista position in Q3 2024.
  • Vanda Pharmaceuticals made up 0.23% of AJOVista's portfolio in Q3 2024, its #97 holding.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.